Papillary thyroid cancer is a type of malignant thyroid tumor. The ICD-10 code for this disease is C73.
C73 is a billable ICD code used to specify a diagnosis of malignant neoplasm of thyroid gland. A 'billable code' is detailed enough to be used to specify a medical diagnosis. The ICD code C73 is used to code Poorly differentiated thyroid cancer
Thyroid cancer metastatic to unspecified site. Clinical Information. A primary or metastatic malignant neoplasm affecting the thyroid gland. ICD-10-CM C73 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc.
poorly differentiated thyroid carcinoma (pdtc) is malignant neoplasm of follicular cell origin showing intermediate histopathological patterns between differentiated and undifferentiated thyroid cancers. Use Additional Code note means a second code must be used in conjunction with this code.
Leukemia, unspecified, in remission C95. 91 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C95. 91 became effective on October 1, 2021.
ICD-10 C73: Papillary thyroid ca.
thyroid and the pathology states papillary microcarcinoma or micropapillary carcinoma, code 8260 is correct. a specific histologic type.
Family history of malignant neoplasm of other organs or systems. Z80. 8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z80.
9: Fever, unspecified.
E89. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E89.
C73 - Malignant neoplasm of thyroid gland | ICD-10-CM.
E04. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E04.
Total thyroidectomy involves the removal of the entire thyroid gland. This procedure is most often performed to treat thyroid cancer, but it may also be performed to treat uncontrollable hyperthyroidism or goiter that causes severe symptoms.
ICD-10 code Z85. 850 for Personal history of malignant neoplasm of thyroid is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Code C80. 1, Malignant (primary) neoplasm, unspecified, equates to Cancer, unspecified.
ICD-10 code: Z80. 8 Family history of malignant neoplasm of other organs or systems.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
A primary or metastatic malignant neoplasm affecting the thyroid gland.
poorly differentiated thyroid carcinoma (pdtc) is malignant neoplasm of follicular cell origin showing intermediate histopathological patterns between differentiated and undifferentiated thyroid cancers.
Use Additional Code note means a second code must be used in conjunction with this code. Codes with this note are Etiology codes and must be followed by a Manifestation code or codes.
DRG Group #011-013 - Tracheostomy for face, mouth and neck diagnoses with MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code C73. Click on any term below to browse the alphabetical index.
The ICD-10-CM Neoplasms Index links the below-listed medical terms to the ICD code C73. Click on any term below to browse the neoplasms index.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 193 was previously used, C73 is the appropriate modern ICD10 code.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
Code C80.0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried.
Code C80.1, Malignant ( primary) neoplasm, unspecified, equates to Cancer, unspecified. This code should only be used when no determination can be made as to the primary site of a malignancy. This code should rarely be used in the inpatient setting.